Mesenchymal stem cell therapy (Tc Erciyes University)

N/A

Report date: 2025/02/28 10:17:27

Base Information

Drug NameMesenchymal stem cell therapy (Tc Erciyes University)
Drug Alias NameWharton Jelly-derived Mesenchymal Stem Cells therapy (Tc Erciyes University)
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRetinitis PigmentosaPeriapical PeriodontitisShock, Septic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTurkey
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTc Erciyes University
China Registration ClassN/A

Develop Information

Active CompaniesTc Erciyes University
Inactive CompaniesN/A
Active IndicationsRetinitis PigmentosaPeriapical Periodontitis
Inactive IndicationsShock, SepticSepsis

Other Information

ATC CodeN/A
Related LinksN/A